Amongst the first in the world: Sheba and National Institutes of Health (NIH) are developing a pan corona vaccine to combat future global outbreaks. Join us in this captivating video for the SPRI seminar, as we delve into the remarkable journey of Sheba’s Infection Prevention and Control Unit, led by Prof. Regev-Yochay. This dedicated team recruited over 9,000 healthcare workers to conduct long-term studies during the COVID-19 pandemic.
This groundbreaking collaboration between Sheba, the Vaccine Research Center, Walter Reed Army Institute of Research, and Sanofi aims to create a vaccine covering a range of coronaviruses. The seminar highlights achievements, scientific findings, and future pandemic preparations, addressing concerns like emerging variants and the needs of the immunosuppressed population. Tune in to hear insights from SPRI leadership, Prof. Gili Regev-Yochay, and Dr. Daniel Douek, SPRI Senior Scientific Advisor of the NIH, as we pave the way for a resilient future in global health.
For more information about Sheba Medical Center, visit www.sheba-global.com